Clinical Trials

Bio News | Clinical Trials | Collaborations & Alliances | Industry News | R&D

Altasciences Acquires SNBL's Preclinical Testing Business

Will add comprehensive preclinical safety testing services to Altasciences’ full service clinical and bioanalytical offerings

08.15.18

Mustang Bio, St. Jude Partner for X-SCID

Most common form of severe combined immunodeficiency, affecting approximately one in 50,000 to 100,000 newborns worldwide

08.13.18

Denali Announces Positive Phase I Study Results

The study involved DNL201, a small molecule inhibitor of leucine-rich repeat kinase 2

08.03.18

Theravance Announces Positive Phase II Results

For TD-9855, a once-daily norepinephrine & serotonin reuptake inhibitor in development for treatment of symptomatic nOH

08.01.18

Bio News | Clinical Trials | Drug Development | Industry News | Trials & Filings

Athenex Announces Positive Phase 3 Endpoints

Both studies, KX-AK-003 and KX-AK-004, had achieved their primary endpoint of 100% clearance of actinic keratosis lesions

07.26.18

Clinical Trials | CRO News | Information Technology

PPD Expands Central Labs’ Preclarus Technology

Features new client portal, functionality improvements, investigator site portal and a new companion mobile app

07.25.18

Clinical Trials | Collaborations & Alliances | Industry News | R&D

Takeda, Ovid Detail Clinical Development Program

The companies plan to initiate three clinical trials to investigate the potential of TAK-935/OV935

07.18.18

Bio News | Clinical Trials | Industry News | R&D

Roche Phase III Study Meets Primary Objective

Assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu

07.17.18

Clinical Trials | Drug Development | Industry News | Information Technology

CluePoints, ONO in Four-Year RBM Pact

ONO will utilize CluePoints’ centralized statistical monitoring platform

07.13.18

Streamlining the Clinical Process

Richard Young, vice president at Veeva, shares insight on what companies can do to further expedite the clinical process

Online Exclusives07.12.18

Clinical Trials | Drug Development | Regulatory Affairs

Are EMA-Style Rules for First-in-Human Trials Coming to North America?

Insights from the 2018 DIA Global Meeting

Beatrice Setnik, Ph.D., Vice President, Scientific and Clinical Strategy, Early Phase, Syneos Health 07.03.18

Clinical Trials | Drug Development | Industry News | Information Technology | R&D

Sanofi Launches Global R&D Ops in China

New global R&D operations hub focused on digitalization and big data analysis

07.02.18

Clinical Trials | Collaborations & Alliances | Industry News

Kymab, Roche Partner to Evaluate KY1044

Roche to provide PD-L1 blocking antibody atezolizumab in combination in Kymab’s upcoming Phase I-II clinical studies

06.28.18

Clinical Trials | Drug Development | Information Technology

Report Reveals Drug Development Innovations Positively Impact Trial Timelines

Adaptive, patient-centric, precision medicine, and real-world data trials increase likelihood of market launch by 10-21%

06.25.18

Clinical Trials | CRO News | Information Technology

ICON Enhances Endpoint Adjudication Services

Will leverage AG Mednet's comprehensive electronic endpoint adjudication system

06.11.18

GE, XPH Enter FlexFactory Agreement

To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization

06.07.18

Clinical Trials | Drug Development | Industry News | Information Technology

Ready for ASCO

Why ASCO’s annual meeting is one of the most important events in the oncology community

Dr. Eric Groves, Vice President of Strategic Drug Development, R&D Solutions, IQVIA 06.01.18

Clinical Trials | CRO News | Laboratory Testing

ACM Global Labs Adds New Testing Services for Oncology Trials

Introduces therapeutic service offering to support the specific testing needs of oncology clinical trials

06.01.18

Breaking News | Clinical Trials | Collaborations & Alliances | Industry News

PPD and NeoGenomics Form Global Strategic Alliance

Expanding global oncology testing for clinical trials